Corcept Therapeutics CORT
NASDAQ CORT
$114.15 -0.59 (-0.51%)
As of: Sep 30, 2026 · 1:30 PM EDT

Corcept Therapeutics Inc (CORT) Net Cash Flow (2010 - 2026)

Updated

Corcept Therapeutics' Net Cash Flow was $2.26 million in Q2 2026, down 80.3% from $11.49 million a year earlier.

Analysis

Corcept Therapeutics Inc (CORT) Net Cash Flow (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Corcept Therapeutics' Net Cash Flow was $8.9 million through Jun 30, 2026; for FY2025, it came in at -$8.61 million.

  • In earlier years, Net Cash Flow was -$7.66 million in FY2024, $68.86 million in FY2023, -$11.29 million in FY2022 and $1.43 million in FY2021 (-96.8%).
  • Quarterly Net Cash Flow has moved between -$127.57 million (Q2 2023) and $233.61 million (Q1 2023) over five years.
  • Per Business Quant data, CORT's Net Cash Flow in the three quarters before Q2 2026 was -$11.47 million (Q1 2026), -$4.61 million (Q4 2025) and $22.71 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.26 Mn
Mar 31, 2026 -11.47 Mn
Dec 31, 2025 -4.61 Mn
Sep 30, 2025 22.71 Mn
Jun 30, 2025 11.49 Mn
Mar 31, 2025 -38.20 Mn
Dec 31, 2024 -8.87 Mn
Sep 30, 2024 8.17 Mn
Jun 30, 2024 -21.16 Mn
Mar 31, 2024 14.20 Mn
Dec 31, 2023 23.39 Mn
Sep 30, 2023 -60.58 Mn
Jun 30, 2023 -127.57 Mn
Mar 31, 2023 233.61 Mn
Dec 31, 2022 16.09 Mn
Sep 30, 2022 14.90 Mn
Jun 30, 2022 -26.52 Mn
Mar 31, 2022 -15.76 Mn
Dec 31, 2021 -17.07 Mn
Sep 30, 2021 -742,000.00
API Access

Corcept Therapeutics Inc Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=CORT&period=max&api_key=YOUR_API_KEY